Dry eye is one of the most common reasons adults seek eye care, and many people cycle through drops, warm compresses, and in-office treatments. A new systematic review looks at low-level light therapy (LLLT), sometimes called photobiomodulation, used on its own rather than combined with intense pulsed light.
How the review was done
Published in Acta Ophthalmologica, the authors searched MEDLINE, Embase, Scopus, and the Cochrane Central Register for studies of LLLT for dry eye disease. Ten clinical studies with 473 participants were eligible. Typical protocols used wavelengths around 625–640 nm and/or 810–850 nm, with sessions lasting at least 10 minutes.
What improved
Across the pooled analyses, LLLT monotherapy was linked to:
- Lower Ocular Surface Disease Index scores (weighted mean difference about −11.4 points)
- Longer non-invasive tear break-up time (about +1.5 seconds)
- Slightly higher tear meniscus height (about +0.04 mm)
When the team limited sensitivity analyses to eligible randomized trials, the symptom and break-up-time benefits held, while the tear-meniscus finding did not. No adverse events were reported in the included studies.
Where LLLT may fit
The authors suggest LLLT may be a standalone option when combination regimens that include intense pulsed light are not suitable. That does not mean every dry-eye patient needs light therapy. Many people still improve with lid hygiene, environment changes, lubricating drops, and treating meibomian gland dysfunction first.
Practical advice
- Describe your symptoms carefully: burning, fluctuating blur, contact-lens intolerance, and morning stickiness point to different drivers.
- Ask whether your dry eye is mainly aqueous deficiency, evaporative, or mixed before adding devices.
- If you are offered LLLT, ask how many sessions, which wavelengths, and what outcome will be tracked.
- Seek prompt care for sudden vision loss, severe pain, or light sensitivity that is new and intense.
Setting expectations
Device-based dry-eye care works best when lids are cleaned, omega-rich diets or supplements are considered when appropriate, and screen habits improve. LLLT is one more tool in that toolbox, not a replacement for diagnosing why the tear film fails in the first place.
Khanna Vision Institute evaluates dry eye as part of comprehensive care. For more on protecting vision as you age, browse oakparklasik.com.
Source: Low-level light therapy for dry eye disease and meibomian gland dysfunction: A systematic review and meta-analysis (Acta Ophthalmologica (PubMed PMID 42860563), 2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.